Docoh
Loading...

OCGN Ocugen

News

Pro users get this 30m faster
Occugen Shares See Volume; Traders Circulate MumbaiMirror Report Highlighting Production Capacity Of Co's Covaxin Vaccine Will Be Doubled By May-June 2021
12 May 21
News, Contracts, FDA, Movers, Trading Ideas
https://mumbaimirror.indiatimes.com/coronavirus/news/centre-to-augment-manufacturing-capacity-of-covaxin-under-mission-covid-suraksha/articleshow/82575470.cms
FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children
10 May 21
Biotech, Government, News, Health Care, FDA, General
The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10
Cantor Fitzgerald Downgrades Ocugen to Neutral, Lowers Price Target to $11
7 May 21
News, Downgrades, Price Target, Analyst Ratings
Cantor Fitzgerald analyst Kristen Kluska downgrades Ocugen (NASDAQ:OCGN) from Overweight to Neutral and lowers the price target from $15 to $11.
Top 20 Searched Tickers In Benzinga Pro For Morning Of Friday, May 7, 2021
7 May 21
Trading Ideas
SemiLEDs (LEDS) Stealth BioTherapeutics (MITO) iBio (IBIO) Peloton (PTON) Ocugen (OCGN) ALFI (ALF) Tesla (TSLA) Roku (ROKU) S&P 500 (SPY) Square (SQ) Nemaura Medical (NMRD) Lexaria Biosciences
Benzinga Pro's Top 5 Stocks To Watch For Friday, May 7, 2021: JMIA, TLRY, WKHS, LEDS, OCGN
7 May 21
Pre-Market Outlook
Today's 5 Stock Ideas Jumia (JMIA) - Andrew Left of Citron Research on Thursday appeared on Benzinga's "PreMarket Prep At The Close" YouTube show to go over his thesis in Jumia. Left
12 Health Care Stocks Moving In Friday's Pre-Market Session
7 May 21
Pre-Market Outlook, Markets, Movers
Ocugen Q1 EPS $(0.04) Up From $(0.07) YoY
7 May 21
Earnings, News
Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.
72 Biggest Movers From Yesterday
7 May 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 85.8% to settle at $10.22 on above-average volume.
Earnings Scheduled For May 7, 2021
7 May 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter.
Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study
6 May 21
Biotech, News, Health Care, Small Cap, General
58 Stocks Moving In Thursday's Mid-Day Session
6 May 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
6 May 21
Pre-Market Outlook, Markets, Movers
Ocugen Highlights Presentation Of Preclinical OCU200 Data At The Association For Research In Vision And Ophthalmology 2021 Annual Meeting
6 May 21
Biotech, News, Events, General
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19,
30 Stocks Moving in Thursday's Pre-Market Session
6 May 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related macular degeneration at the 2021 ARVO Annual Meeting.
Ocugen Shares Spike Higher; Traders Circulate Hindu Business Line Report Titled 'Ocugen to seek emergency-use nod for Covaxin in US market'
5 May 21
News, FDA, Movers, Trading Ideas
https://www.thehindubusinessline.com/companies/ocugen-to-seek-emergency-use-nod-for-covaxin-in-us-market/article34480901.ece
64 Biggest Movers From Yesterday
5 May 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Tuesday's Intraday Session
4 May 21
Intraday Update, Markets, Movers
44 Stocks Moving In Tuesday's Mid-Day Session
4 May 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
4 May 21
Pre-Market Outlook, Markets, Movers
52 Biggest Movers From Yesterday
4 May 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday.

Press releases

Pro users get this 30m faster
Thinking about buying stock in Sundial Growers, Palisade Bio, Ocugen, Farmmi, or Bank of America?
13 May 21
Opinion, Press Releases
NEW YORK, May 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, PALI, OCGN, FAMI, and BAC.
Thinking about buying stock in Palantir Technologies, Ocugen, RA Medical Systems, AMC Entertainment, or Zomedica?
12 May 21
Opinion, Press Releases
NEW YORK, May 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLTR, OCGN, RMED, AMC, and ZOM.
Thinking about buying stock in Sundial Growers, Plug Power, Naked Brand, Ocugen, or Nano Dimension?
11 May 21
Opinion, Press Releases
NEW YORK, May 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, PLUG, NAKD, OCGN, and NNDM.
Thinking about buying stock in Sundial Growers, Palantir Technologies, Ocugen, Nokia, or Transocean?
10 May 21
Opinion, Press Releases
NEW YORK, May 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, PLTR, OCGN, NOK, and RIG.
Thinking about buying stock in Acasti Pharma, Ocugen, Castor Maritime, Naked Brand, or Auris Medical?
7 May 21
Opinion, Press Releases
NEW YORK, May 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACST, OCGN, CTRM, NAKD, and EARS.
Ocugen Provides Business Update and First Quarter 2021 Financial Results
7 May 21
Earnings, News, Press Releases
Conference Call and Webcast Today at 8:30 a.m. ET COVAXIN demonstrates 100% efficacy against severe COVID-19 disease (including hospitalization)Master File submitted for U.S. Food and Drug Administration review prior to
Ocugen Inc to Host Earnings Call
7 May 21
Earnings, News, Press Releases
NEW YORK, NY / ACCESSWIRE / May 7, 2021 / Ocugen Inc (NASDAQ:OCGN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 7, 2021 at 8:30 AM Eastern Time.To listen to the
Thinking about buying stock in Nemaura Medical, Ocugen, Ambev, Precipio, or Vaxart?
6 May 21
Opinion, Press Releases
NEW YORK, May 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NMRD, OCGN, ABEV, PRPO, and VXRT.
Ocugen Presents New Preclinical OCU200 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
6 May 21
News, Health Care, Press Releases
OCU200, a transferrin-tumstatin fusion protein, demonstrates potential to treat DME, DR, and Wet-AMDOCU200 reduced neovascularization and damage to retina and demonstrated comparable/slightly improved activity to
Thinking about buying stock in Cocrystal Pharma, Ocugen, Ault Global, Naked Brand, or Vaxart?
5 May 21
Opinion, Press Releases
NEW YORK, May 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for COCP, OCGN, DPW, NAKD, and VXRT.
Thinking about buying stock in Farmmi, Naked Brand, Ocugen, Ashford Hospitality Trust, or FuelCell Energy?
4 May 21
Opinion, Press Releases
NEW YORK, May 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, NAKD, OCGN, AHT, and FCEL.
Thinking about buying stock in Sundial Growers, Ocugen, Seanergy Maritime, Zomedica, or United States Steel?
4 May 21
Opinion, Press Releases
NEW YORK, May 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, OCGN, SHIP, ZOM, and X.
Ocugen to Host Conference Call on Friday, May 7 at 8:30 a.m. ET to Discuss First Quarter 2021 Financial Results and Provide Business Update
3 May 21
News, Press Releases
MALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a
Thinking about buying stock in Ashford Hospitality Trust, Vaxart, Ocugen, Viracta Therapeutics, or Protalix Biotherapeutics?
3 May 21
Opinion, Press Releases
NEW YORK, May 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, VXRT, OCGN, VIRX, and PLX.
Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2
3 May 21
Press Releases
COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variantPotential effectiveness against multiple variants reduces the possibility of mutant virus escapeAccording to World
Thinking about buying stock in Farmmi, Microvision, Ocugen, Cinedigm, or AMC Entertainment?
30 Apr 21
Opinion, Press Releases
NEW YORK, April 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, MVIS, OCGN, CIDM, and AMC.
Thinking about buying stock in Vaxart, Uxin, Microvision, Ocugen, or Plug Power?
29 Apr 21
Opinion, Press Releases
NEW YORK, April 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VXRT, UXIN, MVIS, OCGN, and PLUG.
Thinking about buying stock in Ocugen, Castor Maritime, Uxin, FuelCell Energy, or 22nd Century Group?
27 Apr 21
Opinion, Press Releases
NEW YORK, April 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCGN, CTRM, UXIN, FCEL, and XXII.
Thinking about buying stock in Ocugen, Microvision, Marathon Digital, Casper Sleep, or Riot Blockchain?
26 Apr 21
Opinion, Press Releases
NEW YORK, April 26, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCGN, MVIS, MARA, CSPR, and RIOT.
Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market
23 Apr 21
Markets, Press Releases
MALVERN, Pa., April 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing